Portfolio

Investments

View all

GlycoMimetics, Inc.

Small molecule therapeutics that mimic the action of carbohydrates to treat inflammatory and infectious diseases

Sector: Biopharmaceuticals, Healthcare
Company Status: Private
Investment Status: Current

Board Members:
James Barrett, PhD

Back to Previous